BlackRock Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.17M Sell
7,964
-23,003
-74% -$3.33M ﹤0.01% 1777
2016
Q3
$3.91M Sell
30,967
-47,100
-60% -$5.68M ﹤0.01% 1201
2016
Q2
$8.8M Sell
78,067
-21,781
-22% -$2.26M 0.01% 884
2016
Q1
$10.4M Sell
99,848
-10,390
-9% -$993K 0.01% 792
2015
Q4
$12.4M Sell
110,238
-5,969
-5% -$660K 0.01% 723
2015
Q3
$12.7M Buy
116,207
+35,773
+44% +$3.83M 0.01% 687
2015
Q2
$7.69M Buy
80,434
+12,159
+18% +$1.14M 0.01% 847
2015
Q1
$6.36M Buy
68,275
+16,887
+33% +$1.48M 0.01% 918
2014
Q4
$4.21M Sell
51,388
-13,662
-21% -$1.05M ﹤0.01% 1013
2014
Q3
$4.17M Sell
65,050
-14,160
-18% -$867K ﹤0.01% 1011
2014
Q2
$4.82M Buy
79,210
+12,049
+18% +$711K ﹤0.01% 978
2014
Q1
$4.02M Sell
67,161
-35,067
-34% -$2.16M ﹤0.01% 1013
2013
Q4
$6.51M Sell
102,228
-105,522
-51% -$6.79M 0.01% 932
2013
Q3
$14.1M Buy
207,750
+172,643
+492% +$12.3M 0.01% 671
2013
Q2
$2.53M Buy
+35,107
New +$2.32M ﹤0.01% 1104

Other funds holding ICUI

BlackRock Advisors's ICUI Position: Q4 2016 in Review

BlackRock Advisors reduced its ICU Medical (ICUI) stake by 74% in Q4 2016, selling an estimated $3.33M and leaving 7,964 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

BlackRock Advisors first reported a position in ICUI in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.1M in Q3 2013. 248 funds tracked by Wall St. Rank hold ICUI as of Q4 2016.

  • BlackRock Advisors held 7,964 shares of ICU Medical worth $1.17M as of Q4 2016.
  • BlackRock Advisors sold 23,003 ICU Medical shares in Q4 2016, an estimated $3.33M.
  • ICU Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1777 holding.
  • BlackRock Advisors first reported a position in ICU Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's ICU Medical position peaked at $14.1M in Q3 2013.
  • 248 funds tracked by Wall St. Rank held ICU Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.